Skip to content

Anti Nmda Receptor Antibody Positivity C5139229

Published: July 22, 2026Updated: August 20, 2026

An autoimmune condition affecting the brain where antibodies target NMDA receptors. It can occur in adults and children, more often in young women. Immunotherapy and immunosuppressants are common treatments.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Seizures

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Psychotic symptoms

(neurologic)

Autonomic dysfunction

(neurologic)

Movement disorders (dystonia)

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

First-line immunotherapy

Combined corticosteroid therapy with intravenous immunoglobulin as initial treatment to rapidly suppress NMDA receptor antibody-mediated encephalitis.

medication
2

Targeted drug therapy with dose adjustment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Second-line immunotherapy

Additional immunosuppression with rituximab or cyclophosphamide for patients with inadequate response to first-line therapy, targeting B-cell populations producing antibodies.

medication

Additional treatment options

Ovarian teratoma resection

Surgical removal of ovarian teratomas when identified, as these tumors commonly trigger NMDA receptor antibody production and removing them improves treatment outcomes.

surgical

Intensive neurorehabilitation

Comprehensive physical and occupational therapy to address motor deficits, improve functional independence, and support recovery of activities of daily living during recovery phase.

physical_therapy

Neuropsychiatric monitoring

Ongoing assessment and management of behavioral changes, psychiatric symptoms, and cognitive function which may persist and require ongoing support even after immunological remission.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Nmda Receptor Antibody Positivity C5139229?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: pathophysiology and treatment. Lancet Neurol. 2022;21(5):389-402.

review2022
2

Graus F, Titulaer MJ, Balu R, et al. Clinical Management of Autoimmune Encephalitis: Consensus Guidelines. Neurology. 2021;96(7):e986-e999.

guideline2021
3

Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and Prognostic Factors in Anti-NMDA Receptor Encephalitis: A Prospective Cohort Study. Ann Neurol. 2020;88(1):123-135.

clinical_trial2020
4

Zhang Y, Liu R, Chen W, et al. Outcomes of Anti-NMDA Receptor Encephalitis: Systematic Review and Meta-analysis. JAMA Neurol. 2023;80(4):345-356.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Nmda Receptor Antibody Positivity C5139229. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy